Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.49 |
| ▸ | LMNA | P02545 | 3/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | TPMT | P51580 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 3/20 | 0.33 |
| ▸ | GFER | P55789 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11926236 | 0.83 | MAPT (0.43) | ALDH1A1LMNAKMT2AMEN1KDM4E | |
| SCHEMBL11925338 | 0.80 | ATM (0.44) | ALDH1A1LMNAKDM4EHPGDMAPT | |
| SCHEMBL17857849 | 0.75 | PABPC1 (0.63) | ALDH1A1LMNAKMT2AKDM4EHPGD | |
| SCHEMBL12789356 | 0.73 | ALDH1A1 (0.44) | ALDH1A1LMNAKMT2AMEN1CYP1A2 | |
| SCHEMBL11926127 | 0.71 | MAPT (0.37) | ALDH1A1LMNAKMT2AMEN1MAPT | |
| Bromide SCHEMBL27175633 | 0.69 | ALDH1A1 (0.72) | ALDH1A1LMNAKMT2AMEN1KDM4E | |
| Bromide SCHEMBL27175635 | 0.69 | ALDH1A1 (0.68) | ALDH1A1LMNAKMT2AMEN1KDM4E | |
| SCHEMBL16624835 | 0.68 | — | — | |
| SCHEMBL11926384 | 0.68 | CHRNA7 (0.43) | ALDH1A1LMNAKMT2AMEN1KDM4E | |
| Butanone SCHEMBL21932538 | 0.67 | ALDH1A1 (0.59) | ALDH1A1KMT2AMEN1CYP1A2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3233801-B1 | USE OF PARTICULAR PYRIDINIUM SALTS FOR THE TREATMENT OF KERATIN SUBSTANCES, COMPOSITIONS AND IMPLEMENTATION METHODS | OREAL (FR) | 2022-06-08 | — | — | EP | disclosed |
| US-20170340543-A1 | USE OF PARTICULAR PYRIDINIUM SALTS FOR THE TREATMENT OF KERATIN SUBSTANCES, COMPOSITIONS AND IMPLEMENTATION METHODS | L'OREAL (FR) | 2017-11-30 | — | — | US | disclosed |
| WO-2016097413-A1 | USE OF PARTICULAR PYRIDINIUM SALTS FOR THE TREATMENT OF KERATIN SUBSTANCES, COMPOSITIONS AND IMPLEMENTATION METHODS | L'OREAL (FR) | 2016-06-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170340543-A1 | USE OF PARTICULAR PYRIDINIUM SALTS FOR THE TREATMENT OF KERATIN SUBSTANCES, COMPOSITIONS AND IMPLEMENTATION METHODS | KRT18, PLPBP, PNPO | ALDH1A1 535/4885LMNA 1443/4885KMT2A 1799/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.